Investing

Vera Therapeutics : VERA

VERA

Stock Data

$35.20

$0.41 (1.15%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Vera Therapeutics Inc, based in Brisbane, California, is a biotechnology firm dedicated to creating innovative treatments for severe immunological diseases. With a focus on research and development, its flagship product, atacicept, is a pioneering fusion protein aimed at treating immunoglobulin A nephropathy and lupus nephritis through subcutaneous injections in advanced clinical trials. Additionally, Vera is working on MAU868, a monoclonal antibody designed to combat BK viremia infections, showcasing its commitment to addressing unmet medical needs in immunology.

All Vera Therapeutics Articles

2 Articles

Trey Thoelcke | Apr 1, 2026 at 7:35 AM EDT

These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target

The GLP-1 revolution has reshaped biopharma M&A strategy. With Novo Nordisk and Eli Lilly generating tens of billions in annual…

Trey Thoelcke | Feb 5, 2024 at 12:09 PM EST

Insider Buying at These Biotechs Is Huge

As January wound to a close, beneficial owners, executives, and other insiders took advantage of public offerings of stock at…